Icosavax
Latest round
- Series B
Last raised
- Mar 2021
Total raised
- $130M
Investors
- 11
About Icosavax
Founded in 2018 and based in Washington, US, Icosavax, Inc. operates as a biotechnology company that develops vaccines using computationally designed proteins.D. In December 2023, AstraZeneca acquired Icosavax, Inc.1 billion. Icosavax is focused on developing vaccines against infectious diseases that cause severe, life-threatening respiratory illnesses that address important unmet medical needs. Icosavax is also developing VLP vaccine candidates against the respiratory syncytial virus (RSV), human metapneumovirus (hMPV), and SARS-CoV-2 (COVID-19). These vaccine candidates have shown induction of neutralizing antibody titers in preclinical studies and could protect the most vulnerable populations, including older adults. Icosavax, Inc. plans to advance IVX-121 into clinical studies within 2021 and study IVX-121 in young and older adults that will enable the transition to a bivalent RSV/hMPV clinical program.
Who invested in Icosavax
11 investors across 2 rounds
See all investors in Icosavax
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Icosavax
Who invested in Icosavax?
Icosavax has 11 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Icosavax raised?
Icosavax has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Icosavax last raise money?
Icosavax's most recent round on record is a Series B, in Mar 2021.
What does Icosavax do?
Founded in 2018 and based in Washington, US, Icosavax, Inc.
Where is Icosavax headquartered?
Icosavax is headquartered in Seattle, US.
Which VCs invest in companies like Icosavax?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Icosavax's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Icosavax? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.